易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002826 易明医药

已收盘 12-12 15:00:00

{"stockData":{"symbol":"002826","market":"SZ","secType":"STK","nameCN":"易明医药","latestPrice":17.64,"timestamp":1765523025000,"preClose":17.83,"halted":0,"volume":2502400,"delay":0,"changeRate":-0.0107,"floatShares":174000000,"shares":191000000,"eps":0.4504,"marketStatus":"已收盘","change":-0.19,"latestTime":"12-12 15:00:00","open":17.82,"high":17.98,"low":17.58,"amount":44422700,"amplitude":0.0224,"askPrice":17.64,"askSize":48,"bidPrice":17.63,"bidSize":39,"shortable":0,"etf":0,"ttmEps":0.4504,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":17.83,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":19.61,"lowLimit":16.05,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":190677750,"isCdr":false,"pbRate":4.24,"roa":"--","peRate":39.165187,"roe":"10.54%","epsLYR":0.25,"committee":0.746692,"marketValue":3364000000,"turnoverRate":0.0144,"status":1,"floatMarketCap":3075000000},"requestUrl":"/m/hq/s/002826/tweets","defaultTab":"tweets","newsList":[{"id":"2590217155","title":"易明医药：截至2025年12月10日股东数为18,499户","url":"https://stock-news.laohu8.com/highlight/detail?id=2590217155","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590217155?lang=zh_cn&edition=full","pubTime":"2025-12-12 11:36","pubTimestamp":1765510586,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年12月10日公司股东人数多少？易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2025年12月10日，本公司股东数为18,499户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200013663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002826","BK0056","BK0033"],"gpt_icon":0},{"id":"2588474387","title":"易明医药：截至2025年11月28日股东数为18,604户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588474387","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588474387?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:12","pubTimestamp":1764576729,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至11月28日收盘公司的股东人数是多少？谢谢易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2025年11月28日，本公司股东数为18,604户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100015280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","002826","BK0239"],"gpt_icon":0},{"id":"2585446839","title":"易明医药(002826)11月20日股东户数1.89万户，较上期减少10.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585446839","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585446839?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:48","pubTimestamp":1763977694,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2025年11月20日公司股东户数为1.89万户，较10月31日减少2223.0户，减幅为10.51%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至11月20日，化学制药行业平均股东户数为3.44万户。从股价来看，2025年10月31日至2025年11月20日，易明医药区间跌幅为4.77%，在此期间股东户数减少2223.0户，减幅为10.51%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400022654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","002826"],"gpt_icon":0},{"id":"2585311872","title":"易明医药：公司目前没有收购58同城或转转相关资产的计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2585311872","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585311872?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:25","pubTimestamp":1763713542,"startTime":"0","endTime":"0","summary":"公司目前没有通过增发收购、协议收购或增发募资方式收购58同城或者转转等相关资产的计划；上市公司股价受宏观经济、市场环境变化等多种因素影响，敬请投资者理性投资，注意投资风险；公司在秉持平稳、安全运营的前提下，集中资源大力发展现有业务，促进公司稳健发展；公司设有董事会办公室负责投资者关系管理和合规事务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100019959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0033","BK0239","BK0056"],"gpt_icon":0},{"id":"2581819410","title":"股市必读：易明医药(002826)股东户数2.11万户，较上期增加6.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581819410","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581819410?lang=zh_cn&edition=full","pubTime":"2025-11-06 08:06","pubTimestamp":1762387617,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2025年11月5日收盘，易明医药报收于20.22元，下跌0.15%，换手率1.91%，成交量3.32万手，成交额6698.95万元。来自：截至2025年10月31日股东户数环比增长6.1%，户均持股数量下降至9017.0股，表明筹码趋于分散。资金流向11月5日主力资金净流出663.23万元；游资资金净流入336.13万元；散户资金净流入327.1万元。股东户数变动近日易明医药披露，截至2025年10月31日公司股东户数为2.11万户，较10月20日增加1216.0户，增幅为6.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251106/31771328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0033","002826","BK0056","BK0239"],"gpt_icon":0},{"id":"2581792872","title":"易明医药：截至2025年10月31日股东数为21,147户","url":"https://stock-news.laohu8.com/highlight/detail?id=2581792872","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581792872?lang=zh_cn&edition=full","pubTime":"2025-11-05 09:01","pubTimestamp":1762304485,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)11月04日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截止10月31日公司的股东人数是多少？谢谢易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2025年10月31日，本公司股东数为21,147户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500005847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0056","BK0033"],"gpt_icon":0},{"id":"2579130026","title":"易明医药（002826）2025年三季报简析：净利润同比增长95.52%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579130026","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579130026?lang=zh_cn&edition=full","pubTime":"2025-10-30 06:30","pubTimestamp":1761777007,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期易明医药发布2025年三季报。截至本报告期末，公司营业总收入4.89亿元，同比下降4.65%，归母净利润8176.33万元，同比上升95.52%。按单季度数据看，第三季度营业总收入1.78亿元，同比上升10.37%，第三季度归母净利润4420.61万元，同比上升1934.12%。本报告期易明医药盈利能力上升，毛利率同比增幅22.52%，净利率同比增幅101.2%。去年的净利率为7.28%，算上全部成本后，公司产品或服务的附加值一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000005775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826"],"gpt_icon":0},{"id":"2578939954","title":"易明医药(002826)10月20日股东户数1.99万户，较上期增加3.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578939954","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578939954?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:36","pubTimestamp":1761644163,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2025年10月20日公司股东户数为1.99万户，较10月10日增加693.0户，增幅为3.6%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至10月20日，化学制药行业平均股东户数为3.38万户。从股价来看，2025年10月10日至2025年10月20日，易明医药区间跌幅为1.46%，在此期间股东户数增加693.0户，增幅为3.6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800031936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","002826","BK0239","BK0056"],"gpt_icon":0},{"id":"2578980878","title":"易明医药(002826.SZ)发布前三季度业绩，归母净利润8176.33万元，增长95.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578980878","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578980878?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:01","pubTimestamp":1761638483,"startTime":"0","endTime":"0","summary":"智通财经APP讯，易明医药(002826.SZ)发布2025年三季度报告，该公司前三季度营业收入为4.89亿元，同比减少4.65%。归属于上市公司股东的净利润为8176.33万元，同比增长95.52%。归属于上市公司股东的扣除非经常性损益的净利润为3994.73万元，同比增长144.50%。基本每股收益为0.44元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1361182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"易明医药(002826.SZ)发布前三季度业绩，归母净利润8176.33万元，增长95.52%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002826"],"gpt_icon":0},{"id":"2578369052","title":"易明医药：截至2025年10月20日股东数为19,931户","url":"https://stock-news.laohu8.com/highlight/detail?id=2578369052","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578369052?lang=zh_cn&edition=full","pubTime":"2025-10-27 15:42","pubTimestamp":1761550933,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)10月27日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止至2025年10月20日收盘公司股东人数为多少，谢谢！易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2025年10月20日，本公司股东数为19,931户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700016429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","002826"],"gpt_icon":0},{"id":"2575410801","title":"股市必读：易明医药(002826)股东户数1.94万户，较上期减少8.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575410801","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575410801?lang=zh_cn&edition=full","pubTime":"2025-10-13 04:39","pubTimestamp":1760301549,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，易明医药报收于19.15元，上涨1.0%，换手率2.85%，成交量4.97万手，成交额9530.86万元。交易信息汇总资金流向10月10日主力资金净流出311.55万元；游资资金净流出472.49万元；散户资金净流入784.04万元。股本股东变化股东户数变动近日易明医药披露，截至2025年9月30日公司股东户数为1.94万户，较9月19日减少1824.0户，减幅为8.58%。户均持股数量由上期的8968.0股增加至9810.0股，户均持股市值为18.93万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300001593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","002826"],"gpt_icon":0},{"id":"2574641121","title":"易明医药(002826)9月30日股东户数1.94万户，较上期减少8.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574641121","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574641121?lang=zh_cn&edition=full","pubTime":"2025-10-10 17:29","pubTimestamp":1760088575,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2025年9月30日公司股东户数为1.94万户，较9月19日减少1824.0户，减幅为8.58%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.23万户。从股价来看，2025年9月19日至2025年9月30日，易明医药区间跌幅为6.22%，在此期间股东户数减少1824.0户，减幅为8.58%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000027199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002826","BK0033","BK0056"],"gpt_icon":0},{"id":"2571767800","title":"易明医药：博斯泰业绩补偿正常推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2571767800","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571767800?lang=zh_cn&edition=full","pubTime":"2025-09-29 16:21","pubTimestamp":1759134068,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)09月29日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问内蒙古博斯泰对赌协议后续的进展如何？还有投资美国健康公司，剩余尾款支付到公司没有？易明医药回复：尊敬的投资者，您好。博斯泰业绩补偿和彼爱减资事宜均按照相关协议正常推进中，如有进展公司将严格按照相关法律法规及时履行信息披露义务。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900020695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","002826","BK0239"],"gpt_icon":0},{"id":"2569374045","title":"易明医药：截至2025年9月19日股东数为21,261户","url":"https://stock-news.laohu8.com/highlight/detail?id=2569374045","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569374045?lang=zh_cn&edition=full","pubTime":"2025-09-24 08:48","pubTimestamp":1758674890,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)09月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到9月20日的最新股东人数是多少，谢谢！易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司最新下发的股东名册，截至2025年9月19日，本公司股东数为21,261户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092400008728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","002826","BK0033"],"gpt_icon":0},{"id":"2569200521","title":"易明医药新董事会、高管团队落定：付丽华任董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2569200521","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569200521?lang=zh_cn&edition=full","pubTime":"2025-09-22 16:46","pubTimestamp":1758530760,"startTime":"0","endTime":"0","summary":"9月22日，易明医药（002826）发布公告，公司于2025年9月19日召开了2025年第二次临时股东会，选举产生了4名非独立董事和3名独立董事，组成第四届董事会。非独立董事有付丽华（董事长）、黄凌逸、姚艳、李玲（职工代表董事）等，独立董事有何德明、陈燕、王广英。　　在高级管理人员方面，公司聘任了许可为总经理和财务总监，李前进为董事会秘书，童荟颖为内部审计负责人，陈僖为证券事务代表。　　2025年中期，易明医药实现收入3.11亿元，归母净利润3756万元。（文章来源：财中社）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-22/doc-infrkfte6256208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002826","BK0056","BK0033"],"gpt_icon":0},{"id":"2566195738","title":"易明医药：截至2025年9月10日股东数为21,727户","url":"https://stock-news.laohu8.com/highlight/detail?id=2566195738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566195738?lang=zh_cn&edition=full","pubTime":"2025-09-11 15:54","pubTimestamp":1757577245,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)09月11日在投资者关系平台上答复投资者关心的问题。投资者提问：最新一期的股东户数是多少易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司最新下发的股东名册，截至2025年9月10日，本公司股东数为21,727户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100022739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","002826"],"gpt_icon":0},{"id":"2565052191","title":"股市必读：易明医药(002826)股东户数2.08万户，较上期减少1.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565052191","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565052191?lang=zh_cn&edition=full","pubTime":"2025-09-08 01:33","pubTimestamp":1757266388,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，易明医药报收于19.86元，上涨2.53%，换手率5.36%，成交量9.34万手，成交额1.82亿元。股本股东变化股东户数变动截至2025年8月29日，易明医药股东户数为2.08万户，较8月20日减少397户，减幅1.87%；户均持股数量升至9167股，户均持股市值为18.37万元。上市公司股价受宏观经济、市场环境变化等多种因素影响，敬请投资者理性投资，注意投资风险；根据中登结算深圳分公司最新下发的股东名册，截至2025年8月29日，本公司股东数为20,800户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800000430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","002826","BK0056"],"gpt_icon":0},{"id":"2565455642","title":"易明医药(002826)8月29日股东户数2.08万户，较上期减少1.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565455642","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565455642?lang=zh_cn&edition=full","pubTime":"2025-09-05 17:29","pubTimestamp":1757064541,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2025年8月29日公司股东户数为2.08万户，较8月20日减少397.0户，减幅为1.87%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至8月29日，化学制药行业平均股东户数为3.27万户。从股价来看，2025年8月20日至2025年8月29日，易明医药区间跌幅为22.14%，在此期间股东户数减少397.0户，减幅为1.87%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090500029047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","002826","BK0239","BK0056"],"gpt_icon":0},{"id":"2562227449","title":"易明医药：截至2025年8月20日股东数为21,197户","url":"https://stock-news.laohu8.com/highlight/detail?id=2562227449","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562227449?lang=zh_cn&edition=full","pubTime":"2025-08-26 08:39","pubTimestamp":1756168753,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)08月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2025年8月20日，公司股东人数有多少易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2025年8月20日，本公司股东数为21,197户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082600010722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0239","BK0033"],"gpt_icon":0},{"id":"2562262379","title":"股市必读：易明医药（002826）8月22日收盘跌5.91%，主力净流出2881.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562262379","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562262379?lang=zh_cn&edition=full","pubTime":"2025-08-25 05:00","pubTimestamp":1756069245,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘，易明医药报收于21.8元，下跌5.91%，换手率11.06%，成交量19.28万手，成交额4.21亿元。当日关注点交易信息汇总：易明医药收盘报21.8元，跌5.91%，连续2日下跌，近5个交易日中有2日跌幅超5%。前10个交易日资金流向情况：主力资金累计净流入3.52亿元，股价累计上涨4.8%资金流向8月22日主力资金净流出2881.01万元；游资资金净流出577.45万元；散户资金净流入3458.46万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500001050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0033","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765678896139,"stockEarnings":[{"period":"1week","weight":-0.0361},{"period":"1month","weight":-0.1246},{"period":"3month","weight":-0.1032},{"period":"6month","weight":-0.211},{"period":"1year","weight":0.3667},{"period":"ytd","weight":0.7096}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏易明西雅医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"18499人(较上一季度减少0.56%)","perCapita":"9423股","listingDate":"2016-12-09","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区林琼岗路6号","registeredCapital":"19067万元","survey":"　　西藏易明西雅医药科技股份有限公司的主营业务是糖尿病、心血管疾病等老年慢性病症治疗及妇科领域核心产品的开发和研究。公司的主要产品是米格列醇片、醋氯芬酸肠溶片、蒙脱石散、红金消结片、多潘立酮片、阿奇霉素胶囊、氯雷他定片、注射用多种维生素（12）、多种微量元素注射液。截至报告期末，公司拥有发明专利28件，实用新型专利22件，药品注册批件32件，注册商标83件。","listedPrice":6.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"易明医药,002826,易明医药股票,易明医药股票老虎,易明医药股票老虎国际,易明医药行情,易明医药股票行情,易明医药股价,易明医药股市,易明医药股票价格,易明医药股票交易,易明医药股票购买,易明医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}